According to reports, on October 17, 2025, several companies including 中国恒有源集团 (CHYY GP), 方正控股 (FOUNDER HOLD), 摩比发展 (MOBI DEV), 天福 (TENFU), 心玮医疗-B (HEARTCARE-B), VITASOY INT'L (VITASOY INT'L), 首佳科技 (SHOUGANG CENT), 明源云 (MING YUAN CLOUD), 天虹国际集团 (TEXHONG INTL GP), 普华和顺 (PW MEDTECH), 瑞声科技 (AAC TECH), 信利国际 (TRULY INT'L), 创新奇智 (AINNOVATION), 碧桂园服务 (CG SERVICES), 中旭未来 (ZYLOXTB), 康臣药业 (CONSUN PHARMA), 百宏实业 (BILLION IND), 归创通桥-B (ZYLOXTB), 力鸿检验 (LEON INSPECTION), 蒙牛乳业 (MENGNIU DAIRY), 固生堂 (GUSHENGTANG), 希玛眼科 (HANG MEI EYE), 重塑能源 (RENEW ENERGY), 小米集团-W (XIAOMI-W), 联易融科技-W (LINKLOGIS-W), 金涌投资 (GOLDSTREAM INV), 九毛九 (JIUMAOJIU), 安东油田服务 (ANTON OILFIELD), 骏杰集团控股 (GME GROUP), 乐华娱乐 (YH ENT), 网龙 (NETDRAGON), 世界华文媒体 (MEDIA CHINESE), 和铂医药-B (HBM HOLDINGS-B), 医渡科技 (YIDU TECH), 绿城管理控股 (GREENTOWN MGMT), 康宁医院 (KN HOSPITAL), 加科思-B (JACOBIO-B), 彩客新能源 (TSAKER NE), 美丽田园医疗健康 (BEAUTYFARM MED), 四环医药 (SIHUAN PHARM), 云工场 (CLOUDWORKS), 歌礼制药-B (ASCLETIS-B), 北森控股 (BEISEN HOLDING), 百胜中国 (YUM CHINA), 贝壳-W (BEKE-W), 速腾聚创 (ROBOSENSE), and 中通快递-W (ZTO EXPRESS-W) executed share buybacks. Among these, the highest buyback amount came from 小米集团-W (XIAOMI-W), which repurchased 10.7 million shares totaling HKD 494 million.

The buyback details are as follows:

- 小米集团-W (XIAOMI-W): 10.7 million shares, HKD 494 million, Year-to-date repurchases: 27.3 million, Year-to-date repurchases/Total equity: 0.110% - 四环医药 (SIHUAN PHARM): 15.0 million shares, HKD 21.76 million, Year-to-date repurchases: 59.6 million, Year-to-date repurchases/Total equity: 0.647% - 蒙牛乳业 (MENGNIU DAIRY): 1.2 million shares, HKD 16.97 million, Year-to-date repurchases: 18.5 million, Year-to-date repurchases/Total equity: 0.473% - 瑞声科技 (AAC TECH): 300,000 shares, HKD 11.60 million - 速腾聚创 (ROBOSENSE): 290,000 shares, HKD 9.92 million - 中通快递-W (ZTO EXPRESS-W): 445,000 shares, HKD 8.41 million, Year-to-date repurchases: 5.07 million, Year-to-date repurchases/Total equity: 0.630%

(Details for further companies follow in a similar format.)